Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Immunophotonics, Inc.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Celgene
FeRx